PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT - Test2 - elhamkhani - TriplyDB

PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT

PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT

http://www.wikidata.org/entity/Q33818120

about

SELDI-TOF-MS proteomic profiling of serum, urine, and amniotic fluid in neural tube defects.Monoaminergic neuropathology in Alzheimer's disease.Biomarkers for the Early Detection and Progression of Alzheimer's Disease.Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer's Disease.

P2860

Q33940289-26BD6B77-4DEA-461A-9F25-B87BEB1FF5C8 Q38809649-89DA7AC0-07CF-4115-A137-5947BF07036D Q38979999-088CC09B-C08E-4770-8412-26F03DCBCBC8 Q48941650-E11A0977-A35B-4AE9-A485-7BA1F5F6391A

P2860

PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT

http://www.wikidata.org/entity/Q33818120

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT

@ast

PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT

@en

type

label

PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT

@ast

PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT

@en

prefLabel

PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT

@ast

PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT

@en

P1433

Q33818120-9B893959-927C-43B1-9B23-5C82B251B194

P1476

Q33818120-1C5FBB83-ECD4-474D-B07E-2BA89FB83BD1

P2093

Q33818120-A5158087-83F5-42A9-AE18-69448F5E96F7

Q33818120-B4370CAD-E6A6-4F93-B9C6-DF9F3A5277D3

P2860

Q33818120-01898043-535C-428E-B46E-26F9927EA931

Q33818120-02D89612-DA54-430A-A575-BD088BC225BB

Q33818120-05CB92AE-69BC-40E7-8648-220285CFC183

Q33818120-101D159C-16DE-4612-A3C6-23A4ED2BD1BD

Q33818120-33092141-BDEB-435E-A029-8C8AA1E7CC4A

Q33818120-3698F9CA-A538-4BF9-A876-8E5614818E2B

Q33818120-3CE66DA5-2BB0-4B99-93C2-C9C5E406A42B

Q33818120-3E3D5A9D-2FD7-47BE-9A66-27ADD9C3187B

Q33818120-4053924A-8B1B-4E58-9DA1-EF274FE744C0

Q33818120-4562BF79-3CEC-4F41-9A9B-F37192397D32

P2888

Q33818120-82F88A4D-5E83-45AD-8616-EAF5BA05DDBE

P304

Q33818120-E1E18A24-EF95-45E8-8BE9-1616D5F91561

P31

Q33818120-3C230307-BE98-483F-A257-902D164A2DF4

P356

Q33818120-A73A5417-248C-4255-88B6-05A05F966130

P433

Q33818120-15128F29-6B99-4116-816C-B5290C71028E

P478

Q33818120-C7256E72-C588-444D-A92C-753317B189B6

P577

Q33818120-89BFAC84-2B8E-4414-8D55-27EA532D65AD

P5875

Q33818120-6CBCFCF4-289A-4EAF-A903-5CF5B48E3633

P6179

Q33818120-19D03A95-C05B-4463-9318-16AFD3A61854

P698

Q33818120-0E38B160-89FC-4959-9BDC-F88A4DF5406D

P921

Q33818120-D991CD41-976E-48AC-B2A0-13752BE0A969

P932

Q33818120-2356D587-674D-4CFC-878D-50BAA289AE9D

P356

V10134-010-0004-0

P1433

Translational neuroscience

P1476

PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT

@en

P2093

Elliott J Mufson

http://www.w3.org/2001/XMLSchema#string

Scott E Counts

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease.

Hippocampal atrophy and disconnection in incipient and mild Alzheimer's disease.

Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects.

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.

Mild cognitive impairment represents early-stage Alzheimer disease.

Natural history of mild cognitive impairment in older persons.

Mild cognitive impairment: ten years later.

P2888

v10134-010-0004-0

P304

2-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2478/V10134-010-0004-0

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49827231

http://www.w3.org/2001/XMLSchema#string

P6179

1006169639

http://www.w3.org/2001/XMLSchema#string

P698

21311725

http://www.w3.org/2001/XMLSchema#string

P921

P932

3035316

http://www.w3.org/2001/XMLSchema#string